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S ~ Y  
By using calcium ion channel antagonists uch as Verapamil and Nifedipine, we 
demonstrated that calcium ion channels are involved in human chorionic gonadotropin (hCG) 
secretion stimulated by gonadotropin releasing hormone (CaLRH). Addition of 1 ~tM Verapamil 
(Class 1I inhibitor) resulted in an inhibition of GnRH-stimulated hCG secretion by placenta 
without affecting basal release. However, while addition of 10 lxM N'ffedipine (Class I inhibitor) 
resulted only in partial inhibition, significant inhibition was observed at 100 gM concentration a d 
above. These results suggest that calcium ion channels in placenta ppear to be similar although 
not identical with the channels reported in the pituitary. 
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INTRODUCTION 
Human chorionic gonadotropin is a glycoprotein hormone produced by the placenta. It has 
two dissimilar subunits alpha and beta held together by non-covalent interactions (1). It shares 
both structural and functional homology with pituitary LH which is subjected to positive 
modulation by gonadotropin releasing hormone (2,3). Studies from our own laboratory as well as 
from others have shown that hCG synthesis and secretion by placenta is also regulated by GnRH 
(4,5). Earlier studies have established that extracellular calcium is required for the normal 
secretion of hCG by placenta. In addition it has been observed that the presence of calcium is 
obligatory for the increase in hCG secretion following addition of GnRH (6,7). 
Electrophysiologieal studies on pituitary gonadotropes revealed that in the depolarization of the 
Abbreviations used: 
hCG, human chorionic gonadotropin; LH, luteinizing hormone; GnRH, gonadotropin releasing 
hormone; BSS, balanced salt solution; FTI-IP, first trimester human placenta; PRIA, plastic 
tube radioimmunoassay; DMSO, dimethyl sulfoxide; PPO, diphenyl oxazole; POPOP, 1,4-bis[5- 
phenyl-2-oxozolyl]-benzene; EGTA, ethylene glycol-bis (13-aminoethyl ether) N,N,N',N'- 
tetraacetic a id. 
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plasma membrane, voltage fluctuations were not involved in CaaRH stimulated FSH/LH secretion 
(8). However, stimulation of gonadotropin secretion by GnRH was calcium-dependent a d this 
could be inhibited by calcium antagonists; hence it was suggested that the stimulatory effect of 
GnRH was mediated by conductance changes associated with the activation of calcium ion 
channels. Use of Verapamil and Methoxyverapamil which are specific inhibitors for calcium ion 
channels in the pituitary were found to inhibit the GnRH-stimulated LH release in a dose 
dependent manner (9). In view of the fact that results of our studies using human placental minces 
also revealed that GnRH stimulated hCG secretion is mediated by mobilization of extracellular 
calcium, it was felt that calcium ion channels may be involved in the secretory phenomenon asin 
the case of pituitary. In this study an attempt has been made to characterize calcium ion channels 
that mediate hCG secretion in human placenta by using Nifedipine and Verapamil which are 
class I and class II specific inhibitors of calcium ion channels respectively (10). 
MATERIALS AND METHODS 
All the chemicals used were of analytical grade and were obtained from Sarabhai 
Chemicals (Bombay, India). Verapamil, Nifedipine, EGTA, PPO, POPOP and DMSO were 
obtained from Sigma Chemical Co (St Louis, MO, USA). GnRH was a girl from Ayerest and 
Wyeth laboratories (USA). 4SCaCl2 (1.9 C[/mole) was obtained from Bhaba Atomic Research 
center (Bombay, India). Normal BSS at pH 7.2 was prepared with the following composition: 1.3 
mM calcium chloride, 5.4 mM potassium chloride, 0.824 mM magnesium chloride, 116.4 mM 
sodium chloride, 26.2 mM sodium bicarbonate, 0.7 mM sodium dihydrogen phosphate, and 5.6 
mM glucose. Calcium-deficient BSS is the same as BSS except hat calcium chloride was not 
added. Calcium free medium is the same as calcium deficient BSS except hat 1 mM EGTA was 
added to chelate all the calcium, if present as impurity in other chemicals used for making BSS. 
Stock solutions of Verapamil and Nifedipine were always freshly prepared just before use in 
DMSO and dilutions and incubations were carried out in the dark to avoid inactivation of the drug 
by light. 
Effect of addition of calcium ion channel inhibitors on GnRH-stimulated hCG secretion by 
human placenta 
Collection of first trimester human placenta nd incubations were performed as described 
earlier (11). In brief, 80-100 nag of placental minces was incubated with or without CmRH in 0.5 
ml normal BSS or calcium free BSS or different concentrations of Verapamil or Nifedipine at 
37 o C in Dubnoff metabolic shaker for 4 h under 95 % oxygen and 5 % carbon 
dioxide. Following the incubation, the medium was separated by centrifugation at 800 x g, tissue 
was washed extensively with BSS and homogenized in a known volume of BSS. An aliquot &the 
tissue homogenate and medium was used for quantitation fhCG by PRIA (12). Another aliquot 
was used for protein estimation by Lowry's method using BSA as standard (13). 
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Effect of addition of Verapamil on GnRH-stimulated 4SCa uptake by first trimester human 
placental minces 
Placental minces were incubated incalcium deficient BSS for 30 rain at 370 C under 95 % 
oxygen and 5 % carbon dioxide. Following the incubation, the tissue was extensively washed 
with calcium-deficient BSS. One hundred nag of tissue minces was incubated in tubes containing 
2 txCi of 45CaCl2 in normal BSS with or without GnRH (1 lxM) or Verapamil (1-10 taM) or GnRI-I 
+ Verapamil for 5 rnin. At stipulated time points the incubated placental samples were diluted with 
two ml BSS and filtered under vaccum using GFC filters in a 1W_tllipore filter assembly. Filters 
were washed with BSS and the tissue on the filter was digested by boiling in 2 ml of 2 M NaOH. 
An aliquot of the digest was used to determine the radioactivity using 5 ml scintillation fluid 
(10% naphthalene, 7.5 % PPO and 0.3 % POPOP in dioxane). 
RESULTS 
Effect of addition of Verapamil and Nifedipine on GnRH-stimulated hCG secretion 
As expected, addition of GnRH to FTHP minces resulted in 2 fold increase in the hCG 
secreted into the medium over the control (Fig 1). Verapamil at concentrations of 1-50 laM was 
found to inhibit only GnRH-stimulated hCG secretion and had no effect on basal secretion at all 
the concentrations tested (Fig 1). Similarly, addition of N'tfedipine had no effect on basal hCG 
secretion at the concentrations tested, while at 10 mM concentration, only partial inhibition (35.5 
%) of GnRH-stimulated hCG secretion was observed (Fig 2). 
Effect of Verapamil on GnRH-stimulated 45Ca uptake 
Addition ofverapamil a one (1-10 lxM') was found to have no effect on 45Ca up take, while 
it inhibited GnRH-stimulated 45Ca uptake 
more effective (Fig 3). 
at both the concentrations tested with 10 p.M being 
DISCUSSION 
Our earlier studies revealed that GnRH-stimulated hCG release in human placenta depends 
on the presence ofextracellular calcium in the medium (6,7). It was also demonstrated that there 
was a mobilization of calcium within minutes, following addition of GnRH to the placenta (14). 
In the present study the use of calcium ion channel inhibitors revealed that GnRH-stimulated 
extracellular calcium movement into the cytosol takes place through voltage-sensitive calcium ion 
channels. Verapamil addition resulted in an inhibition of GnRH stimulated hCG secretion in 
placenta without affecting basal secretion. An inhibitory effect was observed at low 
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Fig 1. Effect of addition of Verapamil on GnRH-stimulated hCG secretion by 
FTI-IP. Each value is the mean of three observations + standard error. Minced 
FTHP was incubated with no addition (A), with 1 ~ GnRH (B), 1 pM 
Verapamil ( C ), 10 IxM Verapamil (D), 50 gM Verapamil (E), 1 lxM GnRH + 1 
~tM Verapamil (F),I gM GnRH + 10 glVl Verapamil (G) and 1 IxM GnRH + 50 
I.tM Verapamil (H) for 4 h at 37 0 C under 95 % oxygen and 5 % carbon dioxide. 
hCG was quantitated in the medium by PRIA. *p<0.01 compared with control, 
**p<0.01 compared with the group treated with GnRH. 
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Fig 2. Effect of addition of N'ffedipine on CmRH-stimulated hCG secretion by 
FTHP. Each value is the mean of three observations + standard error, l~nc~ 
FTHP was incubated with no addition (A), with 1 gM GnRH (B), 10 gM 
Nifedipine ( C ), 100 gM lffLfedipine (D), 500 gM Nifedipine (E), 1000 gM 
Nifedipine (F), 1 gM C_mRH + 10 gM Nffedipine (G), 1 gM GnRH + 100 gM 
Nifedipine (H), 1 gM GnRH + 500 gM N'ffedipine (I) and 1 gM CmRH + 1000 
gM Nifedipine (J) for 4 h at 37 o C under 95 % oxygen and 5 %~carbon dioxide. 
hCG was quantitated in the medium by PRIA. *p<0.01 compared with control, 
**p<0.01 compared with the group treated with GnRH. 
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Fig 3. Effect of addition of Verapamil on GnthH-stimulated +SCa uptake by FTHP 
minces. Each value is the mean of three observations + standard error, g6nced 
FTHP was incubated in BSS containing no addition (A), with 1 ILM GrtRI-I (B), 1 
IxM Verapamil ( C ), 10 laM Verapamil (D), 1 gM GnRH + 1 IxM Verapamil (E) 
and lmM GnRH + 10 ILM Verapamil (F) for 5 min under 95 % oxygen and 5 % 
carbon dioxide. The tissue was processed for monitoring the radioactive 
calcium.*p<0.01 compared with control, **p<0.01 compared with the group 
treated with GnRH. 
concentrations of 1 raM. However, while Nifedipine showed only a partial inhibition of GnRH- 
stimulated hCG secretion at 10 g_M, a significant inhibition was observed at 100 IxM and above. 
Interestingly, it was reported earlier that Verapamil showed greater inhibition of GnRH-stimulated 
LH secretion in the pituitary and Nifedipine virtually had no effect (15). It should be noted that 
in smooth muscle, the class U inhibitors are less potent and class I inhibitors are the most power- 
ful antagonists of calcium ion channel (10). Although a good deal of information is available on 
the action of these inhibitors at calcium ion channels the precise loci of action within the channel 
remains unclear. The present study suggests that GnRH-stimulated hCG secretion in placenta is
through calcium ion channels which appears to be chemically similar although not identical with 
the channels reported in pituitary gonadotropes, as Nifedipine (class I inhibitor) also inhibited the 
hCG release. Our studies also revealed that verapamil (1-10 gM) inhibited GnRH-stimulated 
45Ca uptake which supports the view that calcium ion channels are involved in GnRH action. 
Further studies are required to characterize how calcium channels of the placenta differ fi, om 
calcium channels present in the pituitary and in smooth muscle. 
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